ANDA 77715, held by Actavis Labs Fl Inc. Bupropion Hydrochloride.
As of Nov 16, 2026, ANDA 77715 (Bupropion Hydrochloride), held by Actavis Labs Fl Inc, was first approved by FDA on Jun 13, 2007, with 15 approved supplements and 0 published complete response letters.
Bupropion hydrochloride extended-release tablets (XL) are an aminoketone antidepressant, indicated for: treatment of major depressive disorder (MDD) prevention of seasonal affective disorder (SAD) 1.1 Major Depressive Disorder (MDD) Bupropion hydrochloride extended-release tablets (XL) are indicated for the treatment of major depressive disorder (MDD), as defined by the Diagnostic and Statistical Manual (DSM). The efficacy of the immediate-release formulation of bupropion was established in two 4-week controlled inpatient trials and one 6-week controlled outpatient trial of adult patients with MDD.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 13, 2007 | Original application | Approved |
| Bupropion Hydrochloride150MG · tablet, extended release;oral | Bupropion Hydrochloride | Rx |
| Bupropion Hydrochloride300MG · tablet, extended release;oral | Bupropion Hydrochloride | Discontinued |
| Oct 23, 2024 | Supplement 50Labeling · Standard review | Approved | None posted |
| Aug 2, 2023 | Supplement 42Labeling · Standard review | Approved | None posted |
| Aug 2, 2023 | Supplement 44Labeling · Standard review | Approved | None posted |
| Aug 2, 2023 | Supplement 45Labeling · Standard review | Approved | None posted |
| Oct 16, 2020 | Supplement 34Labeling · Standard review | Approved | None posted |
| Oct 16, 2020 | Supplement 38Labeling · Standard review | Approved | None posted |
| Dec 20, 2014 | Supplement 31Labeling · Standard review | Approved | None posted |
| Apr 23, 2012 | Supplement 23Labeling | Approved | None posted |
| Aug 30, 2010 | Supplement 22Labeling | Approved | None posted |
| Apr 27, 2010 | Supplement 20REMS | Approved | None posted |
| Feb 4, 2010 | Supplement 18Labeling | Approved | None posted |
| Nov 9, 2009 | Supplement 15Labeling | Approved | None posted |
| Nov 26, 2008 | Supplement 6Labeling | Approved | None posted |
| Nov 26, 2008 | Supplement 7Manufacturing | Approved | None posted |
| Jul 9, 2008 | Supplement 2Labeling | Approved | None posted |
| Jun 13, 2007 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters